fbpx
Knowledge is the first and last step to investing

Dr. Reddy’s signs non-exclusive patent licensing agreement with Takeda to commercialize Vonoprazan, a novel gastrointestinal drug, in India.

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?